Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 2021

View Archived Issues

Janssen describes new dihydroorotate dehydrogenase inhibitors

New CDK7 inhibitors discovered at Lilly

Senda Biosciences identifies aryl hydrocarbon receptor antagonists

New three-prime repair exonuclease 1 inhibitors synthesized at Constellation Pharmaceuticals

Axial Therapeutics discovers Toll-like receptor 2 agonists

REST loss promotes breast cancer tumor progression

AcuraStem presents preclinical data for AS-202 in ALS

Novel CD70-directed CAR-NK cells for the treatment of CD70-positive malignancies

Researchers discover more than 1,300 genes linked to congenital heart disease

PFKFB3 targeting shows promise for treating breast cancer

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

SRSF1 is a therapeutic target for the treatment of breast cancer

Discovery of T-036, a novel brain-penetrant GCS inhibitor for the treatment of Gaucher's disease

Celularity and Sorrento Therapeutics present preclinical data for CAR19-CYNK immunotherapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...